Clinical Trial Update: Implementation of SGLT-2 Inhibitors in Patients With Heart Failure Through a New Digital Strategy [NA]

View source ↗

Summary

A completed clinical trial evaluating a digital strategy to implement SGLT-2 inhibitors in patients with heart failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Canagliflozin (canagliflozin)
• Dapagliflozin (dapagliflozin)
• Empagliflozin (empagliflozin)

Snippet

Sponsor: Morten Schou | Conditions: Heart Failure | NA | Status: COMPLETED